Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition

Abstract: Patients with multiple myeloma (MM) who achieve minimal residual disease (MRD) negativity after upfront treatment have superior outcomes compared with those who remain MRD+. Recently, associations have been shown between specific commensal microbes and development of plasma cell disorders....

ver descrição completa

Detalhes bibliográficos

Principais autores:	Matthew J. Pianko, Sean M. Devlin, Eric R. Littmann, Aisara Chansakul, Donna Mastey, Meghan Salcedo, Emily Fontana, Lilan Ling, Elizabet Tavitian, John B. Slingerland, Ann E. Slingerland, Annelie Clurman, Antonio L.C. Gomes, Ying Taur, Eric G. Pamer, Jonathan U. Peled, Marcel R.M. van den Brink, Ola Landgren, Alexander M. Lesokhin
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2019-07-01
Colecção:	Blood Advances
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2473952920306716
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!